- Policy
- 1 min read
Remdesivir allowed in moderate cases
India’s drug regulator has allowed Mylan to expand the indication of remdesivir to “for moderate Covid-19 patients”
- Updated On Oct 14, 2020 at 04:45 AM IST
Read by:
100 Industry Professionals
Read by
100 Industry Professionals
NEW DELHI: India’s drug regulator has allowed Mylan to expand the indication of remdesivir to “for moderate Covid-19 patients” after the global drug major approached it with a proposal seeking the expansion. “After detailed deliberation the committee recommended for the grant of permission for expansion of the indication for moderate Covid-19 patients in addition to the already approved indication,” said the minutes of the subject expert committee meeting dated October 9. Currently, remdesivir is allowed for emergency/compassionate use in treating severely-ill Covid-19 patients.
- By Teena Thacker ,
- ET Bureau
- Published On Oct 14, 2020 at 04:45 AM IST
COMMENTS
All Comments
By commenting, you agree to the Prohibited Content Policy
PostBy commenting, you agree to the Prohibited Content Policy
PostFind this Comment Offensive?
Choose your reason below and click on the submit button. This will alert our moderators to take actions